NuPathe's P2P Acquisition

NuPathe raised a round of funding on January 21, 2014. Investors include Teva Pharmaceuticals.

NuPathe is a specialty pharmaceutical company developing therapeutic products for the treatment of neurological and psychiatric diseases. NuPathe's product portfolio includes NP101, which will be a t…

Articles about NuPathe's P2P Acquisition: